Practice parameters for the treatment of narcolepsy and other hypersomnias of central origin (Q24648903)

Europe PubMed Central

title

Practice parameters for the treatment of narcolepsy and other hypersomnias of central origin (English)

0 references

main subject

narcolepsy

0 references

author

Timothy I. Morgenthaler

1

Timothy I Morgenthaler

0 references

R Nisha Aurora

6

R Nisha Aurora

0 references

Rama Maganti

10

Rama Maganti

0 references

Rochelle Zak

13

Rochelle Zak

0 references

author name string

Vishesh K Kapur

2

0 references

Terry Brown

3

0 references

Todd J Swick

4

0 references

Cathy Alessi

5

0 references

Brian Boehlecke

7

0 references

Andrew L Chesson

8

0 references

Leah Friedman

9

0 references

Judith Owens

11

0 references

Jeffrey Pancer

Treatment of narcolepsy and other hypersomnias of central origin

12

0 references

language of work or name

English

0 references

publication date

December 2007

0 references

published in

Sleep

0 references

volume

30

0 references

page(s)

1705-11

0 references

issue

12

0 references

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276123

Efficacy and safety of modafinil (Provigil) for the treatment of fatigue in multiple sclerosis: a two centre phase 2 study

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276123

Modafinil for daytime somnolence in Parkinson's disease: double blind, placebo controlled parallel trial

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276123

Modafinil in the treatment of excessive daytime sleepiness in children

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276123

The Kleine-Levin syndrome - effects of treatment with lithium -.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276123

Treatment of excessive daytime sleepiness in patients with Parkinson's disease with modafinil

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276123

Stimulant and anticataplectic effects of reboxetine in patients with narcolepsy: a pilot study.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276123

Rules of evidence and clinical recommendations for the management of patients.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276123

Narcolepsy and its treatment with stimulants. ASDA standards of practice.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276123

The efficacy and safety of armodafinil as treatment for adults with excessive sleepiness associated with narcolepsy.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276123

A randomized trial of the long-term, continued efficacy and safety of modafinil in narcolepsy.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276123

Successful treatment of idiopathic hypersomnia and narcolepsy with modafinil.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276123

A double-blind, placebo-controlled study demonstrates sodium oxybate is effective for the treatment of excessive daytime sleepiness in narcolepsy

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276123

Sodium oxybate improves excessive daytime sleepiness in narcolepsy

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276123

Dose effects of modafinil in sustaining wakefulness in narcolepsy patients with residual evening sleepiness

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276123

Further evidence supporting the use of sodium oxybate for the treatment of cataplexy: a double-blind, placebo-controlled study in 228 patients

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276123

EEG-tomographic studies with LORETA on vigilance differences between narcolepsy patients and controls and subsequent double-blind, placebo-controlled studies with modafinil

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276123

A pilot study on the effects of sodium oxybate on sleep architecture and daytime alertness in narcolepsy

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276123

Effects of modafinil on wakefulness and executive function in patients with narcolepsy experiencing late-day sleepiness

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276123

Sodium oxybate demonstrates long-term efficacy for the treatment of cataplexy in patients with narcolepsy

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276123

Dosing Regimen Effects of Modafinil for Improving Daytime Wakefulness in Patients With Narcolepsy

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276123

Ritanserin improves sleep quality in narcolepsy

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276123

Reduction in excess daytime sleepiness by modafinil in patients with myotonic dystrophy

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276123

Modafinil for the treatment of daytime sleepiness in Parkinson's disease: a double-blind, randomized, crossover, placebo-controlled polygraphic trial.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276123

Modafinil in treatment of fatigue in multiple sclerosis. Results of an open-label study

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276123

Practice parameters for the treatment of narcolepsy: an update for 2000.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276123

A comparison of three different sleep schedules for reducing daytime sleepiness in narcolepsy.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276123

Ritanserin, a 5-HT2 receptor blocker, as add-on treatment in narcolepsy

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276123

A randomized, double blind, placebo-controlled multicenter trial comparing the effects of three doses of orally administered sodium oxybate with placebo for the treatment of narcolepsy

28 November 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18246980

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

A 12-month, open-label, multicenter extension trial of orally administered sodium oxybate for the treatment of narcolepsy

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18246980

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Practice parameters for the use of stimulants in the treatment of narcolepsy. Standards of Practice Committee of the American Sleep Disorders Association

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18246980